Spinal cord infarction in a 41-year-old male patient with COVID-19
- PMID: 33480310
- PMCID: PMC8165895
- DOI: 10.1177/1971400921988925
Spinal cord infarction in a 41-year-old male patient with COVID-19
Abstract
The severe acute respiratory syndrome coronavirus disease 2019 (COVID-19) pandemic, became rapidly recognised by variable phonotypic expressions that involve most major body organs. Neurological complications of severe acute respiratory syndrome coronavirus disease are increasingly encountered in patients with COVID-19 infection, more frequently in patients with severe infection, and develop as a consequence of the neurotropic potential of this virus, secondary cytokine storm and acquired syndrome of COVID-19 coagulopathy. Spinal cord involvement after COVID-19 more commonly includes infectious transverse myelitis, para and post infection myelopathy and, rarely, spinal cord ischaemia related to increased coagulopathy with thromboembolic consequences. We herein report a COVID-19-positive patient with increased coagulopathy and vertebral artery thrombosis leading to posterior circulation and subsequent spinal cord infarction.
Keywords: COVID-19; spinal cord, ischaemia.
Figures


References
-
- Nedeltchev K, Loher TJ, Stepper F, et al. Long-term outcome of acute spinal cord ischemia syndrome. Stroke 2004; 35: 560–565. DOI: 10.1161/01.STR.0000111598.78198.EC - PubMed
-
- Novy J, Carruzzo A, Maeder P, et al. Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol 2006; 63: 1113–1120. DOI: 10.1001/archneur.63.8.1113 - PubMed
-
- Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 2020; 50: 54–67. doi.org/10.1007/s11239-020-02134-3 - PMC - PubMed
-
- Nasr DM, Rabinstein A. Spinal cord infarcts: risk factors, management, and prognosis. Curr Treat Options Neurol 2017; 19: 28. DOI: 10.1007/s11940-017-0464-3 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical